Kala Pharmaceuticals Resubmits New Drug Application for Eysuvis for Dry Eye Disease

5 years ago

by David Miller

951 Views

Written by David Miller

WATERTOWN, Mass.–(BUSINESS WIRE)–May 4, 2020– Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!